Patent Yard Sign in
Canadian application, no grantCanada

Amphipathic molecules as cholesterol and other lipid uptake inhibitors

CA 2249459 A1 · Owner: Boffelli, Dario · Inventors: Hauser, Helmut; Boffelli, Dario

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Cholesterol biosynthesis can be inhibited by suitable inhibitors such as the , statins. However, hypercholesterolaemia whether familial or diet-induced, and more generally hyperlipidaemia are not adequately addressed by cholesterol biosynthesis inhibitors alone, since the body's cholesterol is acquired by uptake from the diet as well as by endogenous synthesis. Lipid is also taken up from the gut. This problem is addressed by providing one or more molecules having amphipathic regions to inhibit the uptake of cholesterol and other , lipids, from the gut. Obesity may also be treated or prevented in this way as , may atherosclerosis. Examples of suitable molecules having amphipathic …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 27, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 27, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 27, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 27, 1997
GrantedNo grant recorded
Term endedMarch 27, 2017
Patent numberCA 2249459 A1
Classification (IPC)A61K38/17 +2 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedMarch 27, 1997Term endedMarch 27, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.